Extracts from the stems of the rare Korean Fir show blood clot inhibition effects more than twice as strong as aspirin [2].
This discovery provides a potential pathway for developing new pharmaceutical treatments for thrombosis while highlighting the urgent need to protect a species on the brink of extinction. The research focuses on the plant's unique chemical properties to create medical applications from a dwindling natural resource.
The findings center on the Korean Fir found in the Hwaaksan Mountain area of Gapyeong County, South Korea [1]. According to researchers, only 15 trees of this species remain in the wild [1]. Climate change has caused a sharp decline in the population, leaving the remaining trees vulnerable.
Chae Jung-woo, a researcher at the Gyeonggi Province Forest Environment Research Institute, said the stem extracts contain powerful components that suppress blood coagulation [1]. The study indicates these components are significantly more effective than existing treatments like aspirin [2].
Because the species is so rare, the institute is pursuing a strategy of conservation combined with commercial utilization. The goal is to leverage the plant's medicinal value to ensure the survival of the species, and the development of new health products.
"It has been proven that Korean Fir extracts can be utilized in a wide variety of health functional foods and medicines," Chae said. "Through this research, we plan to begin the development of various products and medicines through technology transfers."
Researchers are currently working on patents and commercialization efforts to transition these laboratory findings into clinical applications. The project aims to balance the industrial potential of the extract with the ecological necessity of preserving the remaining 15 trees [1].
“extracts from the stems of the rare Korean Fir show blood clot inhibition effects more than twice as strong as aspirin”
The identification of a high-potency anticoagulant in a nearly extinct species creates a tension between pharmaceutical exploitation and biological conservation. While the discovery could lead to a breakthrough in cardiovascular medicine, the extreme scarcity of the source material means that synthetic replication of the active compound will be essential for any viable commercial drug development.
